Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-10-20 2022-11-07 172316
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-11-17 2022-12-21 175191
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-01-05 2023-02-17 179942
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-02-17 2023-03-28 185068
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-03-30 2023-04-12 188286
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-04-28 2023-05-05 191155
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-13 2023-09-23 204210
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-09-17 2021-09-28 145805
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-08 2021-12-21 150760
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-02-03 2022-02-17 154155

Showing 11 to 20 of 197

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102

Showing 1 to 10 of 11